Multiple Myeloma an incurable disease, but I have spent the last 25 years in remission using a blend of conventional oncology and evidence-based nutrition, supplementation, and lifestyle therapies from peer-reviewed studies that your oncologist probably hasn't told you about.
Click the orange button to the right to learn more about what you can start doing today.
“Studies have also shown that bortezomib (velcade) is also effective in patients with MM who present with renal failure (kidney disease). Hello Mr.Emerson- My name is Tammy. I’m writing this
Continue reading“The high-dose (dexamethasone) regimen came up very short, with remarkably low survival rate compared with the low-dose regimen,” he said…” Hi David- I was diagnosed with Multiple Myeloma
Continue reading“Kidney failure is a serious complication of multiple myeloma, and up to 50% of patients with this most frequent haematological malignancy may develop some form of renal impairment…” You’ve
Continue reading“…high-dose melphalan caused an approximately 2.5-fold greater mutation accumulation rate than the rate for RVD only…” Everyone knows that chemotherapy and radiation cause side
Continue readingNewly Diagnosed Multiple Myeloma Patients Don’t Know What They Don’t Know- MM Cancer Coaching provides info and therapies- both conventional and non. I was diagnosed with multiple myeloma (MM),
Continue readingMM patients who undergo an autologous stem cell transplant and DO achieve a long overall survival (15 years!) develop a variety of long-term and late stage side effects including: Hi David- What supplements
Continue reading“The findings of this study shed a new light with respect to some of the novel mechanisms underlying the antitumor action of Dichloroacetate (DCA) and thus may have immense clinical applications.” “It
Continue readingBisphosphonate therapy side effects include- Upset Stomach/Esophageal Inflammation, Osteonecrosis of the Jaw, Bone, Joint, and Muscle Pain, Femur Fracture Hi David- I’ve been following PeopleBeatingCancer
Continue reading“However, hematopoietic stem cell transplantation (HSCT) survivors are at risk of developing long-term complications, such as endocrinopathies, musculoskeletal disorders, cardiopulmonary compromise
Continue reading